seca Presents Real-Time Body Composition Tracker for GLP-1 Patients

by Roman Kasianov   •     

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email   |  

seca, a global Hamburg-based medical measurement company founded in 1840, has introduced a new software platform called "Treatment Tracker," which integrates patients' body composition measurements with their clinical treatment plans. 

The tool aims to provide healthcare providers with real-time monitoring of physiological changes—such as fat mass, muscle mass, and total body weight—in response to clinical interventions, allowing providers to make more timely adjustments to treatments.

According to seca, traditional approaches have kept treatment data and body composition analysis separate, typically requiring healthcare teams to consolidate information from multiple sources manually. The Treatment Tracker software is designed to combine these data sources into one visual interface, which the company claims may help clinicians more effectively monitor treatment outcomes.

seca Medical Body Composition Analyzer

seca states the platform can track personalized, evidence-based targets for patients and visualize how body composition changes in response to interventions such as dietary adjustments, exercise regimens, medication, and surgical procedures. Additionally, the software allows clinicians to proactively monitor metrics such as muscle preservation and fat-free mass, facilitating timely modifications to therapy, medication, or lifestyle adjustments.

The company suggests that this approach could promote shared decision-making between providers and patients by offering a clearer view of treatment progress and allowing both parties to align clinical strategies with patient goals.

seca, currently managed by fourth-generation family members Robert Vogel (CEO Marketing & Sales) and Frederik Vogel (CEO Development & Manufacturing), has specialized in medical measuring devices for over 180 years. Originally founded as a scale factory by A.C.C. Joachims in 1840, seca has since grown into a global supplier of medical measurement tools, exporting products to over 110 countries.

Topics: HealthTech   

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email